Amicus Brief Filed in RPX Corp. v. Chanbond LLC: Patient and public interest actors should have the same rights as drugmakers to appeal IPR decisions to the courts to prevent unmerited patents.

25 Jul 2018
Next resource:

Public Comment Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session

 View All resources

Partner with us now to build
a more just and equitable
medicine system for all.